About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
ABBV - AbbVie Inc.| Previous Close | $104.20 | Open | $104.98 |
| Volume | 4.42M | Market Cap | 183.962B |
| Yield | 4.53 % | Last Dividend | $4.72 |
| The Daily Biotech Pulse: Revance's DAXI ... | 11/25/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 24) Abb... | |
| Alembic Pharma's JV Aleor Dermaceuticals... | 11/25/20 |
| New Delhi: Drug firm Alembic Pharmaceuticals on Wednesday said its joint venture Aleor Dermaceuticals has received tentative nod from the US health re... | |
| Biopharmaceuticals Market Will Be Massiv... | 11/23/20 |
| Global Biopharmaceuticals Market Synopsis: The report covers a forecast and an analysis of the Biopharmaceuticals Market on a global and regional leve... | |
| Global Cancer Care Market 2020:The Next ... | 11/23/20 |
| Global Cancer Care market research report utilizes a SWOT analysis as well as Porter???s Five Forces analysis to reveal the strengths, weaknesses, opp... | |
| Global Bi Syndrome Treatment Market 2020... | 11/20/20 |
| This Bi Syndrome Treatment report provides complete analysis of the market on global and regional level. It inspects the development rate and the mark... | |
| Global Biologics Market Outlook On Key G... | 11/20/20 |
| Data Bridge Market research presents the top quality and comprehensive Biologics research report which provides clear insights into market dynamics an... | |
| Biopharmaceuticals Market 2020 Research ... | 11/19/20 |
| Global Biopharmaceuticals Market Analysis, Size, Share, and Forecast to 2020-2027 is a professional and in-depth research report on the world???s majo... | |
| Adalimumab Market Undertakes Strapping G... | 11/19/20 |
| Global Adalimumab Market report brings into light key market dynamics of the sector. It provides guidelines about planning of advertising and sales pr... | |
| Impact Analysis of Covid-19 On Testoster... | 11/19/20 |
| Increasing prevalence of hypogonadism in adult men worldwide is expected to drive growth of the testosterone replacement therapy market. According to ... | |
| PLAQUE PSORIASIS MARKET ANALYSIS BY 2026... | 11/18/20 |
| Plaque Psoriasis Market research report retains focus on other deliverables along with the insights pertaining to the revenue projection, market share... | |
| Berkshire Hathaway Bets Big on Pharmaceu... | 11/18/20 |
| Berkshire Hathaway invested $5.7 billion on four pharmaceutical stocks including AbbVie, Pfizer, Merck, and Bristol-Meyers Squibb Co in Q3. | |
| Obsessive Compulsive Disorder (OCD) Mark... | 11/18/20 |
| All information provided in the report is derived from trusted industrial sources. Global Obsessive Compulsive Disorder (OCD) Market research reports ... | |
| Immuno-Oncology Drugs Market to Observe ... | 11/17/20 |
| Oncology medications are flourishing business for the pharmaceutical industry. Almost the major market players in this field are either manufacturing ... | |
| Veteran investor Bill Smead explains why... | 11/17/20 |
| Summary List Placement Warren Buffett's Berkshire Hathaway added AbbVie, Bristol Myers Squibb, Merck, and Pfizer to its stock portfolio last quarter .... | |
| CAR-T Therapy Treatment Market : COVID-1... | 11/17/20 |
| Analysis and discussion of important industry trends, market size, and market share estimates are revealed in the CAR-T Therapy Treatment Market resea... | |
| Warren Buffett is going all in on the va... | 11/17/20 |
| Warren Buffett???s Berkshire Hathaway continued to liquidate its bank holdings in favor of big pharma, placing big bets on Merck, Pfizer, AbbVie and B... | |
| This Is What Hedge Funds Bought And Sold... | 11/16/20 |
| This Is What Hedge Funds Bought And Sold In Q3: Complete 13F Summary Tyler Durden Mon, 11/16/2020 - 22:20 While we live in a time when the holdings of... | |
| Berkshire Continued To Dump Banks, Bough... | 11/16/20 |
| Berkshire Continued To Dump Banks, Bought New Stakes In Pharma Giants In Q3 Tyler Durden Mon, 11/16/2020 - 17:34 While there were no dramatic changes ... | |
| New Alliance to Address Multiple Pain Po... | 11/16/20 |
| WASHINGTON, Nov. 16, 2020 /PRNewswire/ -- Today, seven women's health-focused organizations ??? the American College of Obstetricians and Gynecologist... | |
| Cytokine Market To Observ Explosive Grow... | 11/12/20 |
| Cytokine Market Report covering detailed analysis, Competitive landscape, forecast, and strategies has been added to the Insight Partners. The study c... | |
| Osteoarthritic Pain Management Treatment... | 11/11/20 |
| Global Osteoarthritic Pain Management Treatment Market, By Type (Hip, Wrist, Spinal, Others), Diagnosis (Imaging), Treatment (Medication, Surgery, The... | |
| Top Analyst Upgrades and Downgrades: Abb... | 11/10/20 |
| No summary available. | |
| Cytokines Market To Register Impressive ... | 11/09/20 |
| ???Global Cytokines Market is estimated to grow at a CAGR of +7% during forecast period 2020- 2025.??? Cytokines are a broad and loose category of sma... | |
| Dry Eye Products Market Will Going to Be... | 11/09/20 |
| The Insight Partners has published a new report titled, Dry Eye Products Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast,... | |
| Reproductive Hormone Market 2020: Intell... | 11/09/20 |
| All information provided in the report is derived from trusted industrial sources. Global Reproductive Hormone Market research reports finds market fi... | |
| Strong Buy rating | 11/18/20 |
| BMO Capital initiates coverage with Outperform rating and announces Price Target of $123.00 | |
| Strong Buy rating | 11/10/20 |
| Bernstein initiates coverage with Outperform rating and announces Price Target of $120.00 | |
| Strong Buy rating | 11/02/20 |
| SVB Leerink maintains Outperform rating and lowers Price Target from $122.00 to $119.00 | |
| Buy rating | 10/23/20 |
| Truist Securities initiates coverage with Buy rating and announces Price Target of $110.00 | |
| Strong Buy rating | 10/16/20 |
| JP Morgan maintains Overweight rating and raises Price Target from $115.00 to $120.00 | |
| Hold rating | 09/29/20 |
| Berenberg initiates coverage with Hold rating and announces Price Target of $98.00 | |
| Buy rating | 09/02/20 |
| Citigroup maintains Buy rating and raises Price Target from $98.00 to $105.00 | |
| Date | 2020-10-30 (BMO) | Est. (EPS/Rev.) | $2.76/ 12.72B |
| Actual (EPS/Rev.) | $2.83/ $12.90 B | EPS (TTM) | 5.67 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| OptionIncome | random motion | 95.00 % | Subscribe |
| Option Superstars | James Catzen | 76.00 % | Subscribe |
| Alpha Swing Trades | Jonathan | 68.00 % | Follow |
| Rocket Investing | Waqas | 59.00 % | Subscribe |
| Biotech Fund | Scientia Equity Research | 57.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
